Calcium Carbonate-Based Mucoadhesive Microcontainers for Intranasal Delivery of Drugs Bypassing the Blood–Brain Barrier

被引:27
|
作者
Borodina T.N. [1 ]
Trushina D.B. [1 ,2 ,3 ]
Marchenko I.V. [1 ,3 ]
Bukreeva T.V. [1 ,3 ]
机构
[1] Shubnikov Institute of Crystallography of Federal Scientific Research Centre “Crystallography and Photonics” of Russian Academy of Sciences, Leninskii pr. 59, Moscow
[2] Faculty of Physics, Lomonosov Moscow State University, Leninskie Gory 1, b.2, Moscow
[3] National Research Centre “Kurchatov Institute”, pl. Akademika Kurchatova 1, Moscow
基金
俄罗斯基础研究基金会;
关键词
Anesthetic; Avoidance of blood–brain barrier; Calcium carbonate microparticles; Drug delivery; Intranasal administration; Microcontainers; Mucoadhesive polymer;
D O I
10.1007/s12668-016-0212-2
中图分类号
学科分类号
摘要
There is an opinion in the medical associations that intranasal administration of medicine allows direct olfactory transfer of drugs into the central nervous system bypassing the blood–brain barrier. This approach could be a valuable solution to the problem of cerebral pathology treatment. We propose a new system of microcontainers for the delivery of an active component to the brain by intranasal administration. The microcontainers were fabricated on the base of porous calcium carbonate particles modified with mucoadhesive biocompatible polymer or polymer/surfactant coating. Loperamide was encapsulated in the proposed microcontainers as a model drug, which cannot pass the blood–brain barrier. The efficiency of microcontainers loaded with the anesthetic loperamide has been assessed by the formalin test in rats in vivo. The results of the in vivo experiments demonstrate decrease in the pain sensitivity after intranasal administration of proposed system, and benefit of mucoadhesive biocompatible coating aiming to improve the anesthetic effect. © 2016, Springer Science+Business Media New York.
引用
收藏
页码:261 / 268
页数:7
相关论文
共 50 条
  • [41] Delivery of peptide drugs to the brain by adenovirus-mediated heterologous expression of human oligopeptide transporter at the blood-brain barrier
    Toyobuku, H
    Sai, Y
    Kagami, T
    Tamai, I
    Tsuji, A
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2003, 305 (01): : 40 - 47
  • [42] Mesenchymal Stem Cell (MSC)-Based Drug Delivery into the Brain across the Blood-Brain Barrier
    Tashima, Toshihiko
    PHARMACEUTICS, 2024, 16 (02)
  • [43] Peptide-Based Delivery of Oligonucleotides Across Blood-Brain Barrier Model
    Srimanee, Artita
    Regberg, Jakob
    Hallbrink, Mattias
    Kurrikoff, Kaido
    Veiman, Kadi-Liis
    Vajragupta, Opa
    Langel, Ulo
    INTERNATIONAL JOURNAL OF PEPTIDE RESEARCH AND THERAPEUTICS, 2014, 20 (02) : 169 - 178
  • [44] Comparison of focused ultrasound-mediated intranasal delivery and focused ultrasound-induced blood-brain barrier disruption in the delivery of gold nanoclusters to the brainstem
    Ye, Dezhuang
    Zhuang, Xiaohui
    Yue, Yimei
    Taylor, Sara
    Tai, Yuan-chuan
    Rubin, Joshua B.
    Liu, Yongjian
    Chen, Hong
    2018 IEEE INTERNATIONAL ULTRASONICS SYMPOSIUM (IUS), 2018,
  • [45] Moving toward Noninvasive, Focused Ultrasound Therapeutic Delivery of Drugs in the Brain: Prolonged Opening of Blood-Brain Barrier May Not Be Needed
    Klibanov, Alexander L.
    McDannold, Nathan J.
    RADIOLOGY, 2019, 291 (02) : 466 - 467
  • [46] Getting into the brain: liposome-based strategies for effective drug delivery across the blood-brain barrier
    Vieira, Debora B.
    Gamarra, Lionel F.
    INTERNATIONAL JOURNAL OF NANOMEDICINE, 2016, 11 : 5381 - 5414
  • [47] Mfsd2a-based pharmacological strategies for drug delivery across the blood brain barrier
    Wang, Jing-Zhang
    Xiao, Ning
    Zhang, Ying-Zhou
    Zhao, Chao-Xian
    Guo, Xin-Hua
    Lu, Li-Min
    PHARMACOLOGICAL RESEARCH, 2016, 104 : 124 - 131
  • [48] In vitro characterization of odorranalectin for peptide-based drug delivery across the blood–brain barrier
    Ravi K. Sajja
    Predrag Cudic
    Luca Cucullo
    BMC Neuroscience, 20
  • [49] Focused ultrasound induced blood-brain barrier disruption to enhance chemotherapeutic drugs (BCNU) delivery for glioblastoma treatment
    Liu, Hao-Li
    Hua, Mu-Yi
    Chen, Pin-Yuan
    Huang, Chiung-Yin
    Wang, Jiun-Jie
    Wei, Kuo-Chen
    9TH INTERNATIONAL SYMPOSIUM ON THERAPEUTIC ULTRASOUND, 2010, 1215 : 176 - +
  • [50] Transferrin receptor antibody-modified α-cobrotoxin-loaded nanoparticles enable drug delivery across the blood–brain barrier by intranasal administration
    Lin Liu
    Xiangyi Zhang
    Wuchao Li
    Haozhen Sun
    Yan Lou
    Xingguo Zhang
    Fanzhu Li
    Journal of Nanoparticle Research, 2013, 15